ATG Versus OKT3 in the Treatment of Steroid-Resistant Rejection Following Living-Related Donor Renal Transplantation

By Uslu A.   Tokat Y.   Ok E.   Unsal A.   Ilkgul O.   Kaplan H.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2805-2806

Elsevier

Access to resources Recommend Favorite

Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection

By Carvalho M.F.C.   Adoni T.   Saggioro F.P.   Soares V.  

Transplantation Proceedings, Vol. 30, Iss. 6, 1998-09 ,pp. : 2876-2877

Elsevier

Access to resources Recommend Favorite

Long-Term Results After Primary Successful FK 506 Treatment of Steroid- and OKT3-Resistant Rejection in Renal Transplant Recipients

By Kliem V.   Schaumann D.   Ehlerding G.   Eberhard O.K.   Lufft V.   Schlitt H.J.   Pichlmayr R.   Koch K.M.   Brunkhorst R.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2955-2957

Elsevier

Access to resources Recommend Favorite

ALG versus OKT3 for treatment of steroid-resistant rejection in renal transplantation: ten-year follow-up results of a randomized trial

By Stippel D.L.   Arns W.   Pollok M.   Beckurts K.T.E.   Hesse U.J.   Holscher A.H.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2201-2202

Elsevier

Access to resources Recommend Favorite

Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantation

By Kahl A.   Oppert M.   Muller A.R.   Settmacher U.   Lepenies J.   Klupp J.   Kampf D.   Neuhaus P.   Frei U.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2253-2255

Elsevier

Access to resources Recommend Favorite